HIGH LEVELS OF CYTOMEGALOVIRUS ANTIBODY IN PATIENTS REQUIRING VASCULAR SURGERY FOR ATHEROSCLEROSIS

E. Adam, J. L. Probtsfield, J. Burek, C. H. Mccollum, J. L. Melnick, B. L. Petrie, Kent R Bailey, M. E. Debakey

Research output: Contribution to journalArticle

246 Citations (Scopus)

Abstract

157 caucasian male patients undergoing vascular surgery for atherosclerosis and a matched control group of patients with high cholesterol levels were screened for antibodies to cytomegalovirus (CMV) and herpes simplex virus type 1 (HSV1) and type 2 (HSV2), indicative of persistent infection. The prevalence of CMV antibodies was higher in the surgical group than in the control group (90% and 74%, respectively), and a significantly greater percentage (p<0.001) of surgical cases than controls had high titres of CMV antibodies (57% and 26%, respectively). Small but not significant differences in antibodies to HSV1 were observed, and there were no differences in HSV2 antibody titres. For each virus there was no correlation between antibody titre and blood levels of total cholesterol or triglycerides. It is suggested that periodically activated virus may have a role in the pathogenesis of atherosclerosis.

Original languageEnglish (US)
Pages (from-to)291-293
Number of pages3
JournalThe Lancet
Volume330
Issue number8554
DOIs
StatePublished - Aug 8 1987
Externally publishedYes

Fingerprint

Cytomegalovirus
Blood Vessels
Atherosclerosis
Antibodies
Human Herpesvirus 1
Viruses
Control Groups
Human Herpesvirus 2
Hypercholesterolemia
Triglycerides
Research Design
Cholesterol
Infection

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Adam, E., Probtsfield, J. L., Burek, J., Mccollum, C. H., Melnick, J. L., Petrie, B. L., ... Debakey, M. E. (1987). HIGH LEVELS OF CYTOMEGALOVIRUS ANTIBODY IN PATIENTS REQUIRING VASCULAR SURGERY FOR ATHEROSCLEROSIS. The Lancet, 330(8554), 291-293. https://doi.org/10.1016/S0140-6736(87)90888-9

HIGH LEVELS OF CYTOMEGALOVIRUS ANTIBODY IN PATIENTS REQUIRING VASCULAR SURGERY FOR ATHEROSCLEROSIS. / Adam, E.; Probtsfield, J. L.; Burek, J.; Mccollum, C. H.; Melnick, J. L.; Petrie, B. L.; Bailey, Kent R; Debakey, M. E.

In: The Lancet, Vol. 330, No. 8554, 08.08.1987, p. 291-293.

Research output: Contribution to journalArticle

Adam, E, Probtsfield, JL, Burek, J, Mccollum, CH, Melnick, JL, Petrie, BL, Bailey, KR & Debakey, ME 1987, 'HIGH LEVELS OF CYTOMEGALOVIRUS ANTIBODY IN PATIENTS REQUIRING VASCULAR SURGERY FOR ATHEROSCLEROSIS', The Lancet, vol. 330, no. 8554, pp. 291-293. https://doi.org/10.1016/S0140-6736(87)90888-9
Adam E, Probtsfield JL, Burek J, Mccollum CH, Melnick JL, Petrie BL et al. HIGH LEVELS OF CYTOMEGALOVIRUS ANTIBODY IN PATIENTS REQUIRING VASCULAR SURGERY FOR ATHEROSCLEROSIS. The Lancet. 1987 Aug 8;330(8554):291-293. https://doi.org/10.1016/S0140-6736(87)90888-9
Adam, E. ; Probtsfield, J. L. ; Burek, J. ; Mccollum, C. H. ; Melnick, J. L. ; Petrie, B. L. ; Bailey, Kent R ; Debakey, M. E. / HIGH LEVELS OF CYTOMEGALOVIRUS ANTIBODY IN PATIENTS REQUIRING VASCULAR SURGERY FOR ATHEROSCLEROSIS. In: The Lancet. 1987 ; Vol. 330, No. 8554. pp. 291-293.
@article{8ec4ae49c63d432b97827ec936db9f5a,
title = "HIGH LEVELS OF CYTOMEGALOVIRUS ANTIBODY IN PATIENTS REQUIRING VASCULAR SURGERY FOR ATHEROSCLEROSIS",
abstract = "157 caucasian male patients undergoing vascular surgery for atherosclerosis and a matched control group of patients with high cholesterol levels were screened for antibodies to cytomegalovirus (CMV) and herpes simplex virus type 1 (HSV1) and type 2 (HSV2), indicative of persistent infection. The prevalence of CMV antibodies was higher in the surgical group than in the control group (90{\%} and 74{\%}, respectively), and a significantly greater percentage (p<0.001) of surgical cases than controls had high titres of CMV antibodies (57{\%} and 26{\%}, respectively). Small but not significant differences in antibodies to HSV1 were observed, and there were no differences in HSV2 antibody titres. For each virus there was no correlation between antibody titre and blood levels of total cholesterol or triglycerides. It is suggested that periodically activated virus may have a role in the pathogenesis of atherosclerosis.",
author = "E. Adam and Probtsfield, {J. L.} and J. Burek and Mccollum, {C. H.} and Melnick, {J. L.} and Petrie, {B. L.} and Bailey, {Kent R} and Debakey, {M. E.}",
year = "1987",
month = "8",
day = "8",
doi = "10.1016/S0140-6736(87)90888-9",
language = "English (US)",
volume = "330",
pages = "291--293",
journal = "The Lancet",
issn = "0140-6736",
publisher = "Elsevier Limited",
number = "8554",

}

TY - JOUR

T1 - HIGH LEVELS OF CYTOMEGALOVIRUS ANTIBODY IN PATIENTS REQUIRING VASCULAR SURGERY FOR ATHEROSCLEROSIS

AU - Adam, E.

AU - Probtsfield, J. L.

AU - Burek, J.

AU - Mccollum, C. H.

AU - Melnick, J. L.

AU - Petrie, B. L.

AU - Bailey, Kent R

AU - Debakey, M. E.

PY - 1987/8/8

Y1 - 1987/8/8

N2 - 157 caucasian male patients undergoing vascular surgery for atherosclerosis and a matched control group of patients with high cholesterol levels were screened for antibodies to cytomegalovirus (CMV) and herpes simplex virus type 1 (HSV1) and type 2 (HSV2), indicative of persistent infection. The prevalence of CMV antibodies was higher in the surgical group than in the control group (90% and 74%, respectively), and a significantly greater percentage (p<0.001) of surgical cases than controls had high titres of CMV antibodies (57% and 26%, respectively). Small but not significant differences in antibodies to HSV1 were observed, and there were no differences in HSV2 antibody titres. For each virus there was no correlation between antibody titre and blood levels of total cholesterol or triglycerides. It is suggested that periodically activated virus may have a role in the pathogenesis of atherosclerosis.

AB - 157 caucasian male patients undergoing vascular surgery for atherosclerosis and a matched control group of patients with high cholesterol levels were screened for antibodies to cytomegalovirus (CMV) and herpes simplex virus type 1 (HSV1) and type 2 (HSV2), indicative of persistent infection. The prevalence of CMV antibodies was higher in the surgical group than in the control group (90% and 74%, respectively), and a significantly greater percentage (p<0.001) of surgical cases than controls had high titres of CMV antibodies (57% and 26%, respectively). Small but not significant differences in antibodies to HSV1 were observed, and there were no differences in HSV2 antibody titres. For each virus there was no correlation between antibody titre and blood levels of total cholesterol or triglycerides. It is suggested that periodically activated virus may have a role in the pathogenesis of atherosclerosis.

UR - http://www.scopus.com/inward/record.url?scp=0023202743&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023202743&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(87)90888-9

DO - 10.1016/S0140-6736(87)90888-9

M3 - Article

VL - 330

SP - 291

EP - 293

JO - The Lancet

JF - The Lancet

SN - 0140-6736

IS - 8554

ER -